Inj Futures Represents Huge Progress For Injective

Bitnomial Brings $INJ Into Regulated US Derivatives Market

Bitnomial has launched the first US-regulated futures contracts tied to @Injective's native token $INJ, marking a significant step for the finance-optimized Layer-1 blockchain. The product, known as the Injective US Dollar Centi Futures ($IJUC), followed Bitnomial's successful self-certification with the Commodity Futures Trading Commission (CFTC).

Bitnomial launched monthly futures tied to $INJ, giving the asset its first US-regulated derivatives market. The contracts began trading on April 15 on Bitnomial Exchange, a CFTC-regulated designated contract market, and are cleared through Bitnomial Clearinghouse. The contracts are crypto-settled, have monthly expirations, and allow traders to post either crypto or US dollars as margin through the clearinghouse.

Injective now sits alongside Bitcoin, Ethereum, Solana, and XRP in the US-regulated futures market. Institutional clients can access the futures immediately, with retail trading expected to follow via Bitnomial's Botanical platform in the coming weeks.

A Building Block Toward a Spot ETF

The launch carries implications beyond a single product listing. The listing starts a six-month track record that could support a spot exchange-traded fund under US Securities and Exchange Commission (SEC) listing rules. Canary Capital has already filed with the SEC for a staked INJ ETF, and the precedent from Bitcoin and Ethereum suggests regulated futures are typically a prerequisite before spot approval moves forward.

Bitnomial President Michael Dunn described @Injective as having built "one of the more technically ambitious Layer 1 blockchains in the market," citing its onchain order book, cross-chain execution, and near-zero gas fees. Injective co-founder Eric Chen called the listing a validation of institutional demand. Bitnomial also plans to list perpetual futures and options tied to $INJ at a later date.

Bitnomial operates a trading venue, clearinghouse, and brokerage for crypto futures and options regulated by the CFTC. The firm previously listed US-regulated monthly futures tied to Aptos in January.

Sources:
Bitnomial official press release via PR Newswire
Cointelegraph: Bitnomial Launches US-Regulated Injective Futures
CoinInsider: Bitnomial Launches US Injective Futures